Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

[Current state and measures of NSAIDs induced ulcer].

Mizokami Y, Narasaka T, Suzuki H.

Nihon Rinsho. 2011 Oct;69(10):1901-5. Japanese.

PMID:
22073592
2.
3.

Bleeding peptic ulcer in the elderly: risk factors and prevention strategies.

Zullo A, Hassan C, Campo SM, Morini S.

Drugs Aging. 2007;24(10):815-28. Review.

PMID:
17896831
4.

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.

Am J Med. 2005 Nov;118(11):1271-8.

PMID:
16271912
5.

Helicobacter pylori infection and the use of NSAIDs.

Bazzoli F, De Luca L, Graham DY.

Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):775-85. Review.

PMID:
11566040
6.

Helicobacter pylori and nonsteroidal anti-inflammatory drugs.

Chan FK.

Gastroenterol Clin North Am. 2001 Dec;30(4):937-52. Review.

PMID:
11764536
7.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

9.

Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage.

Chan FK.

Eur J Gastroenterol Hepatol. 2002 Jan;14(1):1-3.

PMID:
11782567
10.

[Influence of H. pylori infection on upper gastrointestinal damage].

Kawai T, Fukuzawa M, Moriyasu F, Yamashina A.

Nihon Rinsho. 2010 Nov;68(11):2020-4. Review. Japanese.

PMID:
21061526
11.

Peptic ulcer disease today.

Yuan Y, Padol IT, Hunt RH.

Nat Clin Pract Gastroenterol Hepatol. 2006 Feb;3(2):80-9. Review.

PMID:
16456574
12.

[The choice of selective COX-2 inhibitors].

Hiratsuka T, Sakamoto C.

Nihon Rinsho. 2007 Oct;65(10):1819-23. Review. Japanese.

PMID:
17926530
13.
14.

[Current clinical practice among German Internists regarding the prophylaxis of gastroduodenal ulcers associated with NSAIDs, aspirin and Helicobacter pylori].

Schneider AR, Armbruster S, Mann J, von Römer W, Schuster T, Schepp W.

Z Gastroenterol. 2012 Nov;50(11):1156-60. doi: 10.1055/s-0031-1281754. Epub 2012 Nov 13. German.

PMID:
23150107
15.

[The significance of H. pylori eradication in NSAIDs ulcer].

Kato M, Ono S, Mabe K, Shimizu Y, Asaka M.

Nihon Rinsho. 2011 Jun;69(6):1049-56. Review. Japanese.

PMID:
21688626
16.

[Position of NSAIDs in causal factors of peptic ulcer].

Kato M, Ono S, Nakagawa M, Shimizu Y, Asaka M, Nakagawa S.

Nihon Rinsho. 2007 Oct;65(10):1760-7. Japanese.

PMID:
17926521
17.

Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.

Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P.

Scand J Gastroenterol. 2001 Aug;36(8):817-21.

PMID:
11495076
19.

[Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].

Shimada T, Yamagata M, Hiraishi H.

Nihon Rinsho. 2007 Oct;65(10):1824-9. Review. Japanese.

PMID:
17926531
20.

[Guidelines of prevention and treatment for NSAID-related peptic ulcers].

Lee JH, Lee YC, Jeon SW, Kim JW, Lee SW; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Association of Gastroenterology.

Korean J Gastroenterol. 2009 Nov;54(5):309-17. Korean.

Items per page

Supplemental Content

Write to the Help Desk